Phase 2b data for rosnilimab in rheumatoid arthritis featured as late-breaking oral presentation at ACR Convergence 2025 Phase 1b initiated in celiac disease for ANB033, a CD122 antagonist; top-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback